Enhancing Type 2 Diabetes treatment through peer-learning AI: Creating a support system for healthcare professionals in primary care to source and share optimal self-care interventions and best practice in order to improve care and efficiency
Enhancing Type 2 Diabetes treatment through peer-learning AI: Creating a support system for healthcare professionals in primary care to source and share optimal self-care interventions and best practice in order to improve care and efficiency
批准号:
27744
负责人:
金额:
$68.28万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
**NEED:** The management of Type2 Diabetes costs the NHS £8.8bn per year with patients estimated to account for 15-25% of all appointments at a local surgery level.The 'General Practice Forward View' identifies that all patients with long-term conditions should have a personalised plan of care that includes self-care, social prescribing and active signposting as part of its 10 high impact actions within 5 years.Innovations such as Artificial Intelligence (AI) can play a key role in this - however at present there is no market-ready AI-system to assist Healthcare Professionals (HCP) to do this effectively within their time pressures, in part due to the difficulties associated with deriving, machine taught (machine learning), clinically-safe recommendations from the huge amounts of patient data available to digital health companies.**APPROACH:** The project brings together Healum Ltd (digital health platform developer), Vernova CIC Foundation (NHS), Manchester University (Subcontractor) to develop a peer2peer Learning AI and AI platform to support the self-management of T2D patients through personalised plans of care, support, behaviour change and education.Working with 11 GP Practices and with SBRI support (Project Number:8625456) we have already established feasibility of approach, developed an a prototype collaborative self-care platform and innovative peer-learning algorithm.**FOCUS:** The project's focuses on the refinement of peer2peer algorithms and development of AI, machine learning (ML) algorthims, SnoMed code integration, content classifier and collective intelligence recommendation engine as well as aligning and evaluating the platform in the treatment of Type2 Diabetes (T2D).By harnessing the collective peer2peer intelligence of HCP inputting into the software, combined with aggregate anonymised clinical audit data,we are able to reduce the critical mass of data inputs required to train ML algorithms and provide automatic clinical recommendations with a greater level of data confidence.**IMPACT:** The platform will be integrated with and make use of new SnoMed codes and historical Read codes to act as a classifier - supporting the recommendation of the right content, service and plan to the right patient at the right time - and trialled with 21 GP practices during the project to to form a peer2peer community for providing personalised plans of care, support, behaviour change and education to patients with or at risk of T2D.By improving the management of T2D care workload, we estimate potential for cost saving per practice per annum of £11,304, increasing to £61,254 by Y5 once reductions in microvascular complications are factored in.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黎景卫
-
依托单位:
智能型Type-I光敏分子构效设计及其抗耐药性感染研究
-
批准号:22207024
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:赵琦
-
依托单位:
TypeⅠR-M系统在碳青霉烯耐药肺炎克雷伯菌流行中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:蒋晓飞
-
依托单位:
替加环素耐药基因 tet(A) type 1 变异体在碳青霉烯耐药肺炎克雷伯菌中的流行、进化和传播
-
批准号:LY22H200001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:蔡加昌
-
依托单位:
面向手性α-氨基酰胺药物的新型不对称Ugi-type 反应开发
-
批准号:LY22B020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:李绍玉
-
依托单位:
BMP9/BMP type I receptors 通过激活 PPARα保护心肌梗死的机制研究
-
批准号:LQ22H020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈灵丽
-
依托单位:
C2H2-type锌指蛋白在香菇采后组织软化进程中的作用机制研究
-
批准号:32102053
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邓冰
-
依托单位:
血管阻断型Type-I光敏剂合成及其三阴性乳腺癌光诊疗
-
批准号:62120106002
-
项目类别:国际(地区)合作与交流项目
-
资助金额:255万元
-
批准年份:2021
-
负责人:董晓臣
-
依托单位:
茶尺蠖Type-II环氧性信息素合成酶关键基因的鉴定及功能研究
-
批准号:LQ21C140001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:王倩
-
依托单位:
Chichibabin-type偶联反应在构建联氮杂芳烃中的应用
-
批准号:22078300
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:李景华
-
依托单位: